CLINICAL TRIALS PROFILE FOR ACCUTANE
✉ Email this page to a colleague
All Clinical Trials for ACCUTANE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003564 ↗ | Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | Withdrawn | National Cancer Institute (NCI) | Phase 3 | 1969-12-31 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether giving procarbazine alone or with isotretinoin is more effective for recurrent primary malignant glioma. PURPOSE: Randomized phase III trial to compare the effectiveness of procarbazine alone or with isotretinoin in treating patients with recurrent primary malignant gliomas. |
| NCT00003564 ↗ | Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | Withdrawn | M.D. Anderson Cancer Center | Phase 3 | 1969-12-31 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether giving procarbazine alone or with isotretinoin is more effective for recurrent primary malignant glioma. PURPOSE: Randomized phase III trial to compare the effectiveness of procarbazine alone or with isotretinoin in treating patients with recurrent primary malignant gliomas. |
| NCT00003599 ↗ | Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer | Withdrawn | National Cancer Institute (NCI) | Phase 3 | 1969-12-31 | RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of isotretinoin may be an effective way to prevent lung cancer. Vitamin E may prevent the side effects of isotretinoin therapy. PURPOSE: Randomized clinical trial to study the effectiveness of vitamin E in preventing the side effects of isotretinoin in former and current smokers who are receiving isotretinoin to prevent lung cancer. |
| NCT00003599 ↗ | Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer | Withdrawn | M.D. Anderson Cancer Center | Phase 3 | 1969-12-31 | RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of isotretinoin may be an effective way to prevent lung cancer. Vitamin E may prevent the side effects of isotretinoin therapy. PURPOSE: Randomized clinical trial to study the effectiveness of vitamin E in preventing the side effects of isotretinoin in former and current smokers who are receiving isotretinoin to prevent lung cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ACCUTANE
Condition Name
Clinical Trial Locations for ACCUTANE
Trials by Country
Clinical Trial Progress for ACCUTANE
Clinical Trial Phase
Clinical Trial Sponsors for ACCUTANE
Sponsor Name
